Pentasa Tablets 1g 60 pieces:

• Pentasa extended-release tablets contain mesalazine, which has an anti-inflammatory effect, and is used in chronic intestinal inflammation (ulcerative colitis and Crohn's disease).
• Compared to regular tablets, long-acting tablets allow gradual release of the active substance into the intestine, so that the drug has more time to act in the desired location (intestinal wall).

Usage Instructions:

• Always use this medication exactly as your doctor or pharmacist has told you.
• Contact your doctor or pharmacist if you are not sure.
• The dosage and duration of treatment are determined by the doctor who adapts it specifically for you.
• Call the doctor or hospital or poison control if you have taken too much medication or if the child has accidentally taken the medicine.
• If you forget to take Pentasa, you should not take a double dose to make up for the missed dose.

grown ups:

Dosages vary from person to person:

• The usual dose for treating active ulcerative colitis is up to 4 g once a day or divided into several doses.
• The usual dose for treating active Crohn's disease is up to 4 grams per day divided into several doses.
• The usual dose for maintenance treatment - for both ulcerative colitis and Crohn's disease - is up to 4 grams per day, divided into several doses.
• "However, in mild to moderate ulcerative colitis, the recommended maintenance dose is 2 g once daily."

Children (≥6 years):

• There is limited documentation regarding efficacy in children.
• The dose is individual and determined by the doctor.
• The dose is calculated based on the child's weight.
• In general, a half dose is recommended for children whose body weight reaches 40 kg, and the regular dose for children whose body weight exceeds 40 kg.
• The Pentasa 1 g extended-release tablets must be swallowed whole.
• "On the other hand, Pentasa 500 mg extended-release tablets have a score line and can be divided, but should not be chewed or crushed."
• "To facilitate taking the medication, extended-release tablets (both strengths) can be dissolved in a small amount of water or juice just before taking them."
• The preparation can be taken regardless of the meal.
• "If you think that the effect of extended-release Pentasa tablets is too strong or too weak, you should consult your doctor or pharmacist about this."

Do not use Pentasa:

• If you are allergic to mesalazine or any of the other ingredients of this medication.
• If you are allergic to salicylates,
• If you suffer from severe liver or kidney disorders.

Warnings and precautions:

Talk to your doctor or pharmacist before using Pentasa:

• If you are allergic to sulfasalazine, as in such cases, there may also be a certain risk of allergic reactions to long-term Pentasa tablets (risk of allergy to salicylates).
• If you have liver or kidney dysfunction, further precautions will be agreed upon with the doctor.
• If you are taking some other medications at the same time.
• If you suffer from lung diseases, especially asthma.
• "If there are serious changes in the blood picture or myocarditis and pericarditis (inflammation of the heart muscle and inflammation of the pericardium)."
• You should contact the doctor and stop the treatment.
• Such cases appear in rare instances. Signs of serious changes in the blood picture can include bleeding, bruising, sore throat, and fever. Signs of myocarditis and pericarditis include fever and chest pain followed by shortness of breath.
• "If you have previously suffered from severe rashes or skin peeling, blisters and/or sores in the mouth after using mesalazine."
• "Regarding mesalazine treatment, serious skin reactions have been reported, including Stevens-Johnson syndrome and toxic epidermal necrolysis."
• Stop taking mesalazine and consult a doctor immediately if you experience any of the symptoms associated with severe skin reactions.
• "During your treatment with this medication, your doctor will usually perform blood and urine tests to check kidney function, especially at the beginning of the treatment."
• Kidney stones can form when using mesalazine. Symptoms may include pain in the sides of the abdomen and blood in the urine.
• Make sure to drink enough fluids during mesalazine treatment.
• Talk to your doctor or pharmacist before taking this medicine if you are pregnant or breastfeeding, or think you may be pregnant or are planning to become pregnant.
• The active ingredient in Pentasa crosses the placenta, and the fetus may be affected. Therefore, consult your doctor before using Pentasa if you are pregnant.
• "It is likely that breastfed children may be affected. If the child has diarrhea, breastfeeding should be stopped."
• "Pentasa tablets do not affect driving or operating machinery for long periods or have a minimal effect on the ability to do so."

the components:

• The active ingredient is either 500 mg or 1 g (= 1000 mg) of mesalazine.